+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Alopecia Market Share, Growth & Analysis, By Disease, By Application, By Sales Distribution, By Gender And Segment Forecasts, 2016-2026

  • ID: 5206630
  • Report
  • September 2020
  • Region: Global
  • 286 pages
  • Reports and Data

FEATURED COMPANIES

  • Capillus.
  • Cipla Inc.
  • Cirrus Hair Centers
  • Follica Inc.
  • Johnson
  • Johnson AG

The growing prevalence of diseases that trigger alopecia, such as hyperthyroidism, hypopituitarism, lupus, acute stress disorder, and diabetes, are stimulating market growth.

Market Size - USD 9.08 billion in 2019, Market Growth - CAGR of 5.1%, Market Trends - Growing focus on aesthetic appearance and rise in disposable incomes.

The Global Alopecia Market size is expected to reach 13.65 Billion from USD 9.08 Billion in 2019, delivering a CAGR of 5.1% through 2027. The market growth is driven by the growing prevalence of chronic disorders, such as celiac disease, hypothyroidism, hyperthyroidism, Hodgkin’s disease, acute stress disorder, hypopituitarism, Hashimoto’s disease, lupus, diabetes, Addison’s disease, and others, which trigger alopecia in patients.

Changing lifestyle habits, such as overconsumption of alcohol and tobacco and growing stress levels, are resulting in an increased number of alopecia cases globally. Increasing focus on physical appearance and rising disposable incomes are favoring industry growth.

Hair loss, baldness, or alopecia is referred to hair loss from a certain part of the head. The pattern of hair loss can vary from a small portion of the head to the entire body. Alopecia can lead to psychological distress in many cases. Some general types of the disorder include male-pattern hair loss, female-pattern hair loss, thinning hair/telogen effluvium, and alopecia areata. The cause of female pattern hair loss is not clear. However, male pattern hair loss is caused by a combination of male hormones and a genetic disorder.

The increasing prevalence of oral treatments, licensed topical treatments, such as minoxidil, finasteride, and surgical procedures, such as hair transplantation or replacement, is expected to boost alopecia market growth over the forecast period.

Further key findings from the report suggest

  • The growing prevalence of alopecia areata on account of the rising incidences of autoimmune diseases among the populace, including diabetes, Down’s syndrome, hyperthyroidism, and others, is driving alopecia market growth.
  • Growing focus on the aesthetic appeal and physical appearance among individuals is the key factor contributing significantly to the alopecia market revenue share.
  • The growing popularity of laser treatments as a common non-invasive approach for alopecia is likely to boost the growth of the androgenetic segment.
  • On the basis of disease type, the alopecia areata segment accounted for around 39.30% of the alopecia market share in 2019.
  • Based on application, the dermatology clinics segment contributed a revenue share close to USD 4.69 billion in 2019 and is estimated to gain major traction over the analysis period. The growth can be attributed to effective and suitable medication or therapy prescribed by dermatologists for positive results.
  • In the regional landscape, the Asia Pacific region is estimated to exhibit the fastest growth rate of 5.4% through 2027 on account of a vast population suffering from alopecia along with growing awareness among patients regarding the available therapeutic options in the region.
  • The rise in economic development, coupled with increasing per capita healthcare spending in emerging countries such as China, Singapore, and India, is anticipated to offer major opportunities for the alopecia market.
  • North America region accounted for around 22.30% of the alopecia market share in 2019 and is forecast to grow significantly through 2027 on account of the increasing consumer disposable incomes, rise in the introduction of new drugs, and the complementary initiatives taken by relevant organizations like NAAF and AHLA in the region.
  • Prominent players in the global alopecia market are Cipla Inc., Transitions Hair Pty Ltd., Johnson and Johnson AG, Sun Pharmaceutical Industries Ltd., Cirrus Hair Centers, Merck & Co., Inc., Lexington International LLC, Follica, Inc., Capillus, and Vita-Cos-Med Klett-Loch GmbH, among others.

For the purpose of this study, the analyst has segmented the Global Alopecia Market on the basis of disease, sales distribution, application, gender, and region:

Disease Outlook (Revenue, USD Million; 2017-2027)

  • Alopecia Areata
  • Androgenetic Alopecia
  • Others

Sales Distribution Outlook (Revenue, USD Million; 2017-2027)

  • Prescriptions
  • OTC

Application Outlook (Revenue, USD Million; 2017-2027)

  • Homecare Settings
  • Dermatology Clinics

Gender Outlook (Revenue, USD Million; 2017-2027)

  • Female
  • Male

Regional Outlook (Revenue, USD Million; 2017-2027)

  • North America
  • U.S.
  • Europe
  • Germany
  • U.K.
  • Asia Pacific
  • China
  • India
  • Southeast Asia
  • Latin America
  • Brazil
  • Middle East & Africa

Reasons to Buy the Report

  • A robust analysis and estimation of the Alopecia Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Alopecia market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Capillus.
  • Cipla Inc.
  • Cirrus Hair Centers
  • Follica Inc.
  • Johnson
  • Johnson AG
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018-2026

Chapter 3. Indicative Metrics

Chapter 4. Alopecia Market Segmentation & Impact Analysis
4.1. Alopecia Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rising incidences of chronic diseases
4.2.2.2. Increase in technological advancements in alopecia treatment
4.2.3. Market restraints analysis
4.2.3.1. Expensive treatment
4.2.3.2. Adverse side effects
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis

Chapter 5. Alopecia Market By Disease Insights & Trends
5.1. Disease dynamics & Market Share, 2019 & 2026
5.2. Alopecia Areata
5.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.3. Androgenetic Alopecia
5.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
5.4. Others
5.4.1. Market estimates and forecast, 2016 - 2026 (USD Million)
5.4.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 6. Alopecia Market By Sales distribution Insights & Trends
6.1. Sales distribution dynamics & Market Share, 2019 & 2026
6.2. Prescriptions
6.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
6.3. OTC
6.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
6.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 7. Alopecia Market By Gender Insights & Trends
7.1. Gender dynamics & Market Share, 2019 & 2026
7.2. Male
7.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
7.3. Female
7.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 8. Alopecia Market By Application Insights & Trends
8.1. Application dynamics & Market Share, 2019 & 2026
8.2. Homecare Settings
8.2.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.2.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)
8.3. Dermatology Clinics
8.3.1. Market estimates and forecast, 2016 - 2026 (USD Million)
8.3.2. Market estimates and forecast, by region, 2016 - 2026 (USD Million)

Chapter 9. Alopecia Market Regional Outlook
9.1. Alopecia Market share by region, 2019 & 2026
9.2. North America
9.2.1. North America Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.2.2. North America Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.2.3. North America Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.2.4. North America Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.2.5. North America Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.2.6. US
9.2.6.1. US Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.2.6.2. US Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.2.6.3. US Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.2.6.4. US Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.2.6.5. US Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.3. Europe
9.3.1. Europe Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.2. Europe Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.3.3. Europe Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.3.4. Europe Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.3.5. Europe Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.3.6. UK
9.3.6.1. UK Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.6.2. UK Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.3.6.3. UK Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.3.6.4. UK Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.3.6.5. UK Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.3.7. France
9.3.7.1. France Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.3.7.2. France Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.3.7.3. France Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.3.7.4. France Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.4. Asia-Pacific
9.4.1. Asia-Pacific Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.4.2. Asia-Pacific Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.4.3. Asia-Pacific Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.4.4. Asia-Pacific Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.4.5. Asia-Pacific Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.4.6. China
9.4.6.1. China Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.4.6.2. China Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.4.6.3. China Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.4.6.4. China Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.4.6.5. China Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.4.7. India
9.4.7.1. India Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.4.7.2. India Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.4.7.3. India Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.4.7.4. India Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.4.7.5. India Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.4.8. Japan
9.4.8.1. Japan Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.4.8.2. Japan Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.4.8.3. Japan Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.4.8.4. Japan Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.4.8.5. Japan Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.5. Middle East and Africa
9.5.1. Middle East and Africa Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.5.2. Middle East and Africa Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.5.3. Middle East and Africa Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.5.4. Middle East and Africa Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.5.5. Middle East and Africa Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.6. Latin America
9.6.1. Latin America Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.6.2. Latin America Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.6.3. Latin America Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.6.4. Latin America Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.6.5. Latin America Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)
9.6.6. Brazil
9.6.6.1. Brazil Alopecia Market estimates and forecast, 2016 - 2026, (USD Million)
9.6.6.2. Brazil Alopecia Market estimates and forecast By Disease , 2016 -2026, (USD Million)
9.6.6.3. Brazil Alopecia Market estimates and forecast by Sales distribution, 2016 -2026, (USD Million)
9.6.6.4. Brazil Alopecia Market estimates and forecast by Gender , 2016 -2026, (USD Million)
9.6.6.5. Brazil Alopecia Market estimates and forecast by Application ,2016 -2026, (USD Million)

Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Market positioning
10.5. Strategy Benchmarking
10.6. Vendor Landscape

Chapter 11. Company Profiles
11.1. Cipla, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Disease Insights
11.1.4. Strategic Initiatives
11.2. Sun Pharmaceuticals Industries Ltd.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Disease Insights
11.2.4. Strategic Initiatives
11.3. Johnson & Johnson Services, Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Disease Insights
11.3.4. Strategic Initiatives
11.4. Merck & Co., Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Disease Insights
11.4.4. Strategic Initiatives
11.5. Lexington International LLC
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Disease Insights
11.5.4. Strategic Initiatives
11.6. Cirrus Hair Centers
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Disease Insights
11.6.4. Strategic Initiatives
11.7. Vita-Cos-Med Klett-Loch GmbH
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Disease Insights
11.7.4. Strategic Initiatives
11.8. Transitions Hair Pty Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Disease Insights
11.8.4. Strategic Initiatives
11.9. Follica, Inc.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Disease Insights
11.9.4. Strategic Initiatives
11.10. Capillus
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Disease Insights
11.10.4. Strategic Initiatives
Note: Product cover images may vary from those shown
  • Cipla Inc.
  • Johnson
  • Johnson AG
  • Transitions Hair Pty Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co. Inc.
  • Cirrus Hair Centers
  • Lexington International LLC
  • Vita-Cos-Med Klett-Loch GmbH
  • Follica Inc.
  • Capillus.
Note: Product cover images may vary from those shown
Adroll
adroll